Scholarlink

<p>International travel, especially to areas with higher risk of infection, poses unique risks for infectious and non-infectious issues in patients with history of systemic autoimmune inflammatory diseases.&#xa0;We searched Medline, Scopus, and relevant rheumatology and other professional society guidelines for management of vaccinations and travel medications for immunocompromised travelers.&#xa0;The immune status of travelers with a history of systemic autoimmune inflammatory disease may have an impact on the safety and efficacy of vaccines, especially live-attenuated vaccines. For individuals on immunosuppressive medications, live vaccines are generally contraindicated. However, if safe intervals off immunosuppression are possible, live vaccines may be feasible. Chemoprophylaxis for malaria or acute mountain sickness may be indicated based on travel itinerary.&#xa0;Safe international travel is possible for patients with history of systemic autoimmune inflammatory diseases, including for those receiving immunosuppressive therapy, but may warrant coordination between a patient’s rheumatologist and a travel medicine provider.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

International travel considerations for patients with systemic autoimmune inflammatory diseases in the era of novel immunosuppressive therapies

  • 期刊论文

  • 发表日期：

    2026年6月30日

查看全文
  • Robert J. Rolfe,
  • Simon M. Helfgott,
  • Camille N. Kotton

摘要

International travel, especially to areas with higher risk of infection, poses unique risks for infectious and non-infectious issues in patients with history of systemic autoimmune inflammatory diseases. We searched Medline, Scopus, and relevant rheumatology and other professional society guidelines for management of vaccinations and travel medications for immunocompromised travelers. The immune status of travelers with a history of systemic autoimmune inflammatory disease may have an impact on the safety and efficacy of vaccines, especially live-attenuated vaccines. For individuals on immunosuppressive medications, live vaccines are generally contraindicated. However, if safe intervals off immunosuppression are possible, live vaccines may be feasible. Chemoprophylaxis for malaria or acute mountain sickness may be indicated based on travel itinerary. Safe international travel is possible for patients with history of systemic autoimmune inflammatory diseases, including for those receiving immunosuppressive therapy, but may warrant coordination between a patient’s rheumatologist and a travel medicine provider.